Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ho Bae

Showing results (751-760 of 809) with videos related to

Pageof 81
Sort By:
The American Journal of Cardiology|November 18, 2011
Comparison of outcomes of patients with painless versus painful ST-segment elevation myocardial infarction undergoing percutaneous coronary interventionJae Yeong Cho, Myung Ho Jeong, Young Keun Ahn, et al.
Cardiovascular Drugs and Therapy|April 13, 2010
A multicenter, eight-week treatment, single-step titration, open-label study assessing the percentage of Korean dyslipidemic patients achieving LDL cholesterol target with atorvastatin starting doses of 10 mg, 20 mg and 40 mgCheol Whan Lee, Sang-Hong Baek, Taek-Jong Hong, et al.
Coronary Artery Disease|May 2, 2015
Clinical influence of early follow-up glycosylated hemoglobin levels on cardiovascular outcomes in diabetic patients with ST-segment elevation myocardial infarction after coronary reperfusionJinhee Ahn, Taek Jong Hong, Jin Sup Park, et al.
International Journal of Cardiology|November 19, 2013
Comparative assessment of angiotensin II type 1 receptor blockers in the treatment of acute myocardial infarction: surmountable vs. insurmountable antagonistHae Chang Jeong, Myung Ho Jeong, Youngkeun Ahn, et al.
JACC. Asia|April 18, 2026
Percutaneous Coronary Intervention Guided by Optical Coherence Tomography or Intravascular Ultrasound for True Bifurcation LesionsSeong-Bong Wee, Do-Yoon Kang, Jung-Min Ahn, et al.
Journal of Korean Medical Science|October 5, 2010
Impact of the metabolic syndrome on the clinical outcome of patients with acute ST-elevation myocardial infarctionMin Goo Lee, Myung Ho Jeong, Youngkeun Ahn, et al.
Circulation|September 19, 2022
Everolimus-Eluting Stents or Bypass Surgery for Multivessel Coronary Artery Disease: Extended Follow-Up Outcomes of Multicenter Randomized Controlled BEST TrialJung-Min Ahn, Do-Yoon Kang, Sung-Cheol Yun, et al.
JAMA|August 26, 2020
Effect of Genotype-Guided Oral P2Y12 Inhibitor Selection vs Conventional Clopidogrel Therapy on Ischemic Outcomes After Percutaneous Coronary Intervention: The TAILOR-PCI Randomized Clinical TrialNaveen L Pereira, Michael E Farkouh, Derek So, et al.
International Journal of Cardiology|April 29, 2014
CHA2DS2-VASc scoring system as an initial method for screening high-risk patients in acute myocardial infarctionYoung Wook Jeong, Myung Ho Jeong, Sung Soo Kim, et al.
Clinical Therapeutics|April 21, 2018
Efficacy and Safety of Fixed-dose Combination Therapy With Telmisartan and Rosuvastatin in Korean Patients With Hypertension and Dyslipidemia: TELSTA-YU (TELmisartan-rosuvaSTAtin from YUhan), a Multicenter, Randomized, 4-arm, Double-blind, Placebo-controlled, Phase III StudyGyu Chul Oh, Jung-Kyu Han, Ki Hoon Han, et al.
Pageof 81

Showing results (751-760 of 809) with videos related to

Sort By:
Pageof 81
The American Journal of Cardiology|November 18, 2011
Comparison of outcomes of patients with painless versus painful ST-segment elevation myocardial infarction undergoing percutaneous coronary interventionJae Yeong Cho, Myung Ho Jeong, Young Keun Ahn, et al.
Cardiovascular Drugs and Therapy|April 13, 2010
A multicenter, eight-week treatment, single-step titration, open-label study assessing the percentage of Korean dyslipidemic patients achieving LDL cholesterol target with atorvastatin starting doses of 10 mg, 20 mg and 40 mgCheol Whan Lee, Sang-Hong Baek, Taek-Jong Hong, et al.
Coronary Artery Disease|May 2, 2015
Clinical influence of early follow-up glycosylated hemoglobin levels on cardiovascular outcomes in diabetic patients with ST-segment elevation myocardial infarction after coronary reperfusionJinhee Ahn, Taek Jong Hong, Jin Sup Park, et al.
International Journal of Cardiology|November 19, 2013
Comparative assessment of angiotensin II type 1 receptor blockers in the treatment of acute myocardial infarction: surmountable vs. insurmountable antagonistHae Chang Jeong, Myung Ho Jeong, Youngkeun Ahn, et al.
JACC. Asia|April 18, 2026
Percutaneous Coronary Intervention Guided by Optical Coherence Tomography or Intravascular Ultrasound for True Bifurcation LesionsSeong-Bong Wee, Do-Yoon Kang, Jung-Min Ahn, et al.
Journal of Korean Medical Science|October 5, 2010
Impact of the metabolic syndrome on the clinical outcome of patients with acute ST-elevation myocardial infarctionMin Goo Lee, Myung Ho Jeong, Youngkeun Ahn, et al.
Circulation|September 19, 2022
Everolimus-Eluting Stents or Bypass Surgery for Multivessel Coronary Artery Disease: Extended Follow-Up Outcomes of Multicenter Randomized Controlled BEST TrialJung-Min Ahn, Do-Yoon Kang, Sung-Cheol Yun, et al.
JAMA|August 26, 2020
Effect of Genotype-Guided Oral P2Y12 Inhibitor Selection vs Conventional Clopidogrel Therapy on Ischemic Outcomes After Percutaneous Coronary Intervention: The TAILOR-PCI Randomized Clinical TrialNaveen L Pereira, Michael E Farkouh, Derek So, et al.
International Journal of Cardiology|April 29, 2014
CHA2DS2-VASc scoring system as an initial method for screening high-risk patients in acute myocardial infarctionYoung Wook Jeong, Myung Ho Jeong, Sung Soo Kim, et al.
Clinical Therapeutics|April 21, 2018
Efficacy and Safety of Fixed-dose Combination Therapy With Telmisartan and Rosuvastatin in Korean Patients With Hypertension and Dyslipidemia: TELSTA-YU (TELmisartan-rosuvaSTAtin from YUhan), a Multicenter, Randomized, 4-arm, Double-blind, Placebo-controlled, Phase III StudyGyu Chul Oh, Jung-Kyu Han, Ki Hoon Han, et al.
Pageof 81